All Stories

  1. Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel
  2. Early career psychiatrists’ ability to evaluate and manage negative symptoms of schizophrenia – results from a European survey
  3. Body Image: A Bridge Between Depression and Quality of Life in Women With Cancer
  4. Editorial: Community series in mental-health-related stigma and discrimination: prevention, role, and management strategies, volume III
  5. Beyond diagnosis: Examining body dissatisfaction across obesity and eating disorders
  6. Early Maladaptive Schemas as Core Therapeutic Targets in Eating Disorders and Obesity: A Schema Therapy–Informed Network Analysis
  7. The place of risperidone in situ microparticles (ISM®) among long-acting injectable antipsychotics in schizophrenia treatment
  8. Editorial: Standardizing cognitive endophenotype profiling in bipolar disorder and schizophrenia
  9. Editorial: Safety and side effects of psychotropic medications, volume III
  10. Early Maladaptive Schemas Mediate the Relationship Between Childhood Trauma and Interpersonal Problems in Eating Disorders
  11. The Greater the Number of Altered Eating Behaviors in Obesity, the More Severe the Psychopathology
  12. The Association Between Antipsychotics and Bone Fragility: An Updated Comprehensive Review
  13. Editorial: Biological and non-pharmacological treatments of obsessive-compulsive disorder and related disorders
  14. Latent profile analysis identifies four different clinical schizophrenia profiles through aberrant salience
  15. Aberrant salience mediates the interplay between emotional abuse and positive symptoms in schizophrenia
  16. Applying a clinical staging model in patients affected by schizophrenia spectrum disorder
  17. Metacognition as a transdiagnostic factor across eating disorders: a latent profile analysis study
  18. The European psychiatric association (EPA) – early career psychiatrists committee survey on trainees’ and early-career psychiatrists’ attitudes towards therapeutic drug monitoring (TDM) use and utility during antipsychotic treatment
  19. Editorial: Community series in mental illness, culture, and society: dealing with the COVID-19 pandemic, volume VIII
  20. Immunomodulatory Effects of Clozapine: More Than Just a Side Effect in Schizophrenia
  21. Editorial: The experiences of mental health professionals in psychiatric settings
  22. Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database
  23. Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial
  24. Editorial: Community series in mental-health-related stigma and discrimination: prevention, role, and management strategies, volume II
  25. Obsessive–Compulsive Disorder as an Epiphenomenon of Comorbid Bipolar Disorder? An Updated Systematic Review
  26. The role of arts in moderating mental health-related stigma: views of early career psychiatrists and trainees from different parts of the world
  27. Influence of NUCB/Nesfatin-1 Polymorphism on Treatment Response to Naltrexone/Bupropion SR in Binge Eating Disorder and Obesity
  28. Stigma toward substance use disorders: a multinational perspective and call for action
  29. Using latent class analysis to identify different clinical profiles according to food addiction symptoms in obesity with and without binge eating disorder
  30. Variations in obsessive compulsive disorder symptomatology across cultural dimensions
  31. The Impact of Job on Mental Health
  32. Early career psychiatrists’ perceptions of and training experience in electroconvulsive therapy: A cross-sectional survey across Europe
  33. Impact of stigma on the placement of mental health facilities: insights from early career psychiatrists worldwide
  34. Parity of esteem: A global COVID-19 vaccination approach for people with mental illnesses, based on facts from 34 countries; recommendations and solutions
  35. Editorial: Safety and side effects of psychotropic medications, volume II
  36. Mental illness stigma among perinatal women in low- and middle-income countries: early career psychiatrists' perspective
  37. Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK
  38. Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel
  39. Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database
  40. The relationship of food addiction with binge eating disorder and obesity: A network analysis study
  41. Head Regional Differences in Thermal Comfort: Evaluating a Novel Surgical Helmet Cooling Method with Phase Change Material
  42. Reactive hypoglycemia in binge eating disorder, food addiction, and the comorbid phenotype: unravelling the metabolic drive to disordered eating behaviours
  43. An update from the WPA Working Group on Digitalization in Mental Health and Care
  44. Pain experience in eating disorders: The mediating role of depression, alexithymia and interoceptive awareness
  45. Cognitive biases are associated with aberrant salience experience in schizophrenia spectrum disorders
  46. Defining the minimum clinically important difference (MCID) in the hospital anxiety and depression scale (HADS) in patients undergoing total hip and knee arthroplasty
  47. Collaborative research on mental health in the post-COVID-19 era: an early career psychiatrists' perspective
  48. Esketamine nasal spray in severe bipolar depression with borderline personality disorder and history of multiple substance abuse: A case report
  49. Sleep Disturbances in Panic Disorder with Comorbid Complex PTSD: A Possible Relationship and Different Psychopathology?
  50. Editorial: Community series in mental illness, culture, and society: dealing with the COVID-19 pandemic, volume VII
  51. Systemic Racism, Ethnic Discrimination, and Children’s Mental Health: Fostering Global Conversations
  52. Editorial: Community series in mental illness, culture, and society: dealing with the COVID-19 pandemic, volume VI
  53. Editorial: Community series in mental illness, culture, and society: dealing with the COVID-19 pandemic: volume V
  54. Editorial: Mental health and internalized stigma in people with severe mental illness
  55. Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database
  56. Effectiveness of SGA-LAIs on Clinical, Cognitive, and Social Domains in Schizophrenia: Results from a Prospective Naturalistic Study
  57. Editorial: Community series in mental illness, culture, and society: Dealing with the COVID-19 pandemic - Volume IV
  58. Sleep Disturbances in Generalized Anxiety Disorder: The Role of Calcium Homeostasis Imbalance
  59. Postoperative psychological factors and quality of life but not shoulder brace adherence affect clinical outcomes after arthroscopic rotator cuff repair
  60. Editorial: Safety and side effects of psychotropic medications
  61. Editorial: Community series in mental illness, culture, and society: Dealing with the COVID-19 pandemic - Volume III
  62. Mental health-related stigma in movies: A call for action to the cinema industry
  63. Editorial: Mental-health-related stigma and discrimination: Prevention, role, and management strategies
  64. Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
  65. Editorial: Community series in mental illness, culture, and society: Dealing with the COVID-19 pandemic—Volume II
  66. Editorial: Mental illness, culture, and society: Dealing with the COVID-19 pandemic
  67. The use of antidepressants is linked to bone loss: A systematic review and metanalysis
  68. The Mediation Effect of Peripheral Biomarkers of Calcium Metabolism and Chronotypes in Bipolar Disorder Psychopathology
  69. Brain stimulation and other biological non-pharmacological interventions in mental disorders: An umbrella review
  70. Validation of a novel Psychosis-Implicit Association Test (P-IAT) as a diagnostic support tool
  71. Is everyone invited to the discussion table? A Bibliometric Analysis COVID-19 Related Mental Health Literature
  72. Internalized-stigma and dissociative experiences in bipolar disorder
  73. Aberrant salience correlates with psychotic dimensions in outpatients with schizophrenia spectrum disorders
  74. Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases
  75. 10th EPA Summer School on Research 2021: sharing experience of the first online edition
  76. THE RISING SCOURGE OF MENTAL ILLNESS AND INFODEMIC: AN OUTCOME OF SOCIAL MEDIA AND COVID-19
  77. EFFECTS OF THE GLOBAL ECOLOGICAL CRISIS ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS: AN INTERNATIONAL PERSPECTIVE
  78. The grief experience during the COVID-19 pandemic across different cultures
  79. Two Cases of Olfactory Reference Syndrome Treated with Risperidone
  80. Associations of lockdown stringency and duration with Google searches for mental health terms during the COVID-19 pandemic: A nine-country study
  81. Depression and anxiety among Pakistani healthcare workers amid COVID-19 pandemic: A qualitative study
  82. Nicotine replacement gums dependence: A case report of a new potential addiction
  83. Palatal myoclonus with tinnitus treated as a psychogenic disorder for 35-years
  84. Primary Obsessive Slowness: A Complex Presentation and Treatment Difficulties
  85. Antidepressants and Vertebral and Hip Risk Fracture: An Updated Systematic Review and Meta-Analysis
  86. Pharmacovigilance approaches to study rare and very rare side-effects: the example of clozapine-related DiHS/DRESS syndrome
  87. Neuroimaging correlates of insight in non-affective psychosis: A systematic review and meta-analysis
  88. Support the frontliners – good initiatives during the COVID-19 pandemic for healthcare workers across the world: is this what we really need?
  89. Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond
  90. Development, validation and clinical use of the Eating Behaviors Assessment for Obesity (EBA-O)
  91. Nutrition and Depression
  92. The Mental Health of Caregivers and Their Patients With Dementia During the COVID-19 Pandemic: A Systematic Review
  93. Role and Perspectives of Inflammation and C-Reactive Protein (CRP) in Psychosis: An Economic and Widespread Tool for Assessing the Disease
  94. How to overcome barriers to publication in low‐ and middle‐income countries: Recommendations from early career psychiatrists and researchers from around the world
  95. How is the COVID-19 pandemic affecting women's menstrual cycles and quality of life? A view from South Asia
  96. Awareness of illness moderates self-assessment of psychotic symptoms
  97. Prevalence of impaired kidney function in patients with long‐term lithium‐treatment: a systematic review and meta‐analysis
  98. Dissociative Symptoms in Bipolar Disorder: Impact on Clinical Course and Treatment Response
  99. Olanzapine-Related Somnambulism
  100. La représentation des femmes dans les comités éditoriaux des revues de psychiatrie : multiples défis et obstacles
  101. Fear During COVID-19 pandemic: Fear of COVID-19 Scale Measurement Properties
  102. Mental status via telepsychiatry: The potential pitfalls
  103. Suicidal behavior sociocultural factors in developing countries during COVID-19
  104. Role of Social Media in Psychiatry During Pandemic
  105. A systematic review and pooled, patient‐level analysis of predictors of mortality in neuroleptic malignant syndrome
  106. Impact of videoconferencing applications on mental health
  107. Core clinical manifestations of clozapine-related DRESS syndrome: A network analysis
  108. Executive functions and depressive symptoms interplay in binge eating disorder: A structural equation model analysis
  109. Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile
  110. Neuroimaging correlates of insight in non-affective psychosis: A systematic review and meta-analysis
  111. Suicide is multifactorial: There should be a difference between a news report and a scientific report of suicide
  112. Coronavirus outbreak from early career psychiatrists' viewpoint: What we have learned so far
  113. Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: A systematic review
  114. Challenges and Opportunities of Psychiatric Training During COVID-19: Early Career Psychiatrists’ Perspective Across the World
  115. Current and emerging long-acting antipsychotics for the treatment of schizophrenia
  116. Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression
  117. Internet and Pornography Use During the COVID-19 Pandemic: Presumed Impact and What Can Be Done
  118. COVID-19 & psychiatric care: Need of a plan to prevent follow-up discontinuation
  119. Antisocial Personality Disorder in Bipolar Disorder: A Systematic Review
  120. Clinical Impact of Psychopathy on Bipolar Disorder
  121. Telepsychiatry in Low- and Middle-Income Countries During COVID-19
  122. Matrix Metalloproteinase 9 Blood Alterations in Patients With Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis
  123. Current state of cannabis use, policies, and research across sixteen countries: Cross-Country Comparisons and International perspectives
  124. 24-hour mobile phone helpline service for women discharged from mother-baby psychiatry unit (MBU): Is it possible?
  125. IMPACT OF BIPOLAR DISORDER AND OBSESSIVE-COMPULSIVE DISORDER COMORBIDITY ON NEUROCOGNITIVE PROFILE: A MINI-REVIEW
  126. It’s COVID o’clock—time to publish or perish
  127. Development and Validation of a Computerized Adaptive Assessment Tool for Discrimination and Measurement of Psychotic Symptoms
  128. Effect of COVID-19 on Mental Health Rehabilitation Centers
  129. Infectious disease outbreak related stigma and discrimination during the COVID-19 pandemic: Drivers, facilitators, manifestations, and outcomes across the world
  130. Management of psychiatric conditions and delirium during the COVID-19 pandemic across continents: The lessons thus far
  131. Pathways to orthorexia nervosa: a case series discussion
  132. The urge to implement and expand telepsychiatry during the COVID-19 crisis: Early career psychiatrists’ perspective
  133. Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review
  134. Application of Support Vector Machine on fMRI Data as Biomarkers in Schizophrenia Diagnosis: A Systematic Review
  135. La urgencia de implementar y ampliar la telepsiquiatría durante la crisis de COVID-19: perspectiva de los psiquiatras que inician su carrera
  136. An open-label trial on the efficacy and tolerability of naltrexone/bupropion SR for treating altered eating behaviours and weight loss in binge eating disorder
  137. Second-generation long-acting injections anti-psychotics improve executive functions in patients with schizophrenia: a 12-month real-world study
  138. Sleep Disturbance in Bipolar Disorder: Neuroglia and Circadian Rhythms
  139. ‘Impaired Autonomy and Performance’ predicts binge eating disorder among obese patients
  140. Machine learning techniques in a structural and functional MRI diagnostic approach in schizophrenia: a systematic review
  141. Weight and age do not account for a worse executive functioning among BED-obese patients
  142. Effectiveness of integrated psychological therapy on clinical, neuropsychological, emotional and functional outcome in schizophrenia: a RCT study
  143. Bipolar disorder and obsessive compulsive disorder: The comorbidity does not further impair the neurocognitive profile